Sage Journals: Discover world-class research

Abstract

The aim of this study was to evaluate the epidemiological data and the main comorbidities of patients with erysipelas admitted to a tertiary hospital. All patients admitted due to erysipelas during the period from 1999 to 2008 were included in a prospective and cross-sectional study. The Fisher exact test and logistic regression were used for statistical analysis. A total of 428 individuals were hospitalized with 41 rehospitalizations; 51.17% of the patients were women, the mean age was 58.6 years. The main comorbidities were hypertension (51.6%), diabetes mellitus (41.6%), chronic venous insufficiency (36.2%), other cardiovascular diseases (33.2%) including angina, peripheral arterial insufficiency, acute myocardial infarction, and strokes, obesity (12.1%), chronic renal failure (6.8%), neoplasms (4.9%), cirrhosis (4.9%), chronic lymphedema (4.2%), and leg ulcers (2.6%). Erysipelas is a seasonal disease that affects adults and the elderly people, has a repetitive nature, and is associated with comorbidities.

Keywords

erysipelas comorbidities epidemiology chronic venous

Get full access to this article

View all access options for this article.

References

Török L. Uncommon manifestations of erysipelas. Clin Dermatol. 2005;23(5):515-518.

Bernard P. Management of common bacterial infections of the skin. Curr Opin Infect Dis. 2008;21(2):122-128.

Lazzarini L. , Conti E. , Tositti G. , de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect. 2005;51(5):383-389.

Bernardes CH , Augusto JCA , Lopes LTC , Cardoso KT , Santos Rodrigues J. , Santos LM Clinical experience assessing 284 cases of erysipelas. Annals Brazilian Dermatology . 2002;77:605-9.

Pereira de Godoy JM , Azoubel LM , Guerreiro Godoy Mde F. Erysipelas and lymphangitis in patients undergoing lymphedema treatment after breast-cancer therapy. Acta Dermatovenerol Alp Panonica Adriat. 2009;18(2):63-65.

Bartholomeeusen S. , Vandenbroucke J. , Truyers C. , Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology . 2007;215(2):118-122.

Damstra RJ , van Steensel MA , Boomsma JH , Nelemans P. , Veraart JC Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol. 2008; 158(6):1210-1215.

Brouns E. , Donceel P. , Stas M. Quality of life and disability after ilio-inguinal lymphadenectomy . Acta Chir Belg. 2008;108(6): 685-690.

Baddour LM , Bisno AL Non-group A beta-hemolytic streptococcal cellulitis: association with venous and lymphatic compromise. Am J Med. 1985;79(2):155-159.

10.

Belczak CEQ , Tyszka AL , Godoy JMP , Ramos RN , Belczak SQ , Caffaro RA Clinical complications of limb undergone harvesting of great saphenous vein for coronary artery bypass grafting using bridge. Brazilian. Journal of Cardiovascular Surgery. 2009;24: 68-72.

11.

Mokni M. , Dupuy A. , Denguezli M. , et al. Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study. Dermatology. 2006;212(2):108-112.

12.

Carratalà J. , Rosòn B. , Fernández-Sabè N. , et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22(3): 151-157.

13.

Caetano M. , Amorim I. Erisipela. Acta Méd Port. 2005 ;18:385-94.

14.

Celestin R. , Brown J. , Kihiczak G. , Schwartz RA Erysipelas: a common potentially dangerous infection. Acta Dermatovenerol Alp Panonica Adriat. 2007;16(3):123-127.

15.

Bishara J. , Golan-Cohen A. , Robenshtok E. , Leibovici L. , Pitlik S. Antibiotic use in patients with erysipelas: a retrospective study . Isr Med Assoc J. 2001;3(10):722-724.

16.

Abbade LPF , Lastória S. Management of patients with venous leg ulcer . Ann Bras Dermatol . 2006;81:509-521.

17.

Björnsdóttir S. , Gottfredsson M. , Thórisdóttir AS , Gunnarsson GB , Ríkardsdóttir H. , Kristjánsson M. , et al. Risk Factors for Acute Cellulitis of the Lower Limb: A Prospective Case-Control Study. Clin Infectious Dis. 2005 ;41:1416-22.

18.

de Godoy JM , de Godoy MF , Valente A. , Camacho EL , Paiva EV Lymphoscintigraphic evaluation in patients after erysipelas. Lymphology. 2000;33(4):177-180.

19.

Fernandez J. , Navasa M. , Gomez J. , et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacine prophylaxis . Hepatology. 2002;35(1):140-148.

Epidemiological Data and Comorbidities of 428 Patients Hospitalized With Erysipelas

Abstract

Keywords

Get full access to this article

References